EP0364481A4 - Growth factors - Google Patents

Growth factors

Info

Publication number
EP0364481A4
EP0364481A4 EP19880905578 EP88905578A EP0364481A4 EP 0364481 A4 EP0364481 A4 EP 0364481A4 EP 19880905578 EP19880905578 EP 19880905578 EP 88905578 A EP88905578 A EP 88905578A EP 0364481 A4 EP0364481 A4 EP 0364481A4
Authority
EP
European Patent Office
Prior art keywords
growth factors
growth
factors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880905578
Other versions
EP0364481A1 (en
Inventor
Milton Thomas William Hearn
Joseph Bertolini
Mark Andrew Guthridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Original Assignee
Monash University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monash University filed Critical Monash University
Publication of EP0364481A1 publication Critical patent/EP0364481A1/en
Publication of EP0364481A4 publication Critical patent/EP0364481A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP19880905578 1987-06-18 1988-06-15 Growth factors Withdrawn EP0364481A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2579/87 1987-06-18
AUPI257987 1987-06-18

Publications (2)

Publication Number Publication Date
EP0364481A1 EP0364481A1 (en) 1990-04-25
EP0364481A4 true EP0364481A4 (en) 1992-01-22

Family

ID=31722038

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880905578 Withdrawn EP0364481A4 (en) 1987-06-18 1988-06-15 Growth factors

Country Status (3)

Country Link
EP (1) EP0364481A4 (en)
JP (1) JPH03500529A (en)
WO (1) WO1988010269A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814602A (en) * 1988-03-17 1998-09-29 Novo Nordisk A/S Heparin-binding proteins
AU617795B2 (en) * 1988-03-17 1991-12-05 Leukotech A/S Heparin-binding proteins, dna coding for them, processes for producing them as well as therapeutic preparations containing them
WO1991006668A1 (en) * 1989-10-27 1991-05-16 The Du Pont Merck Pharmaceutical Company Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
AU659723B2 (en) * 1992-02-14 1995-05-25 Kaken Pharmaceutical Co., Ltd. Remedy for airway diseases
NZ538094A (en) * 2002-07-09 2007-01-26 Baxter Int Serum free and animal protein free culture medium for cultivation of cells
US7598356B2 (en) * 2004-07-08 2009-10-06 Board of Regents of the University of Nebraska by and on behalf of the University of Nebraska Medical Center Method for purifying a protein of the cystine-knot superfamily

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288687A2 (en) * 1987-03-03 1988-11-02 Takeda Chemical Industries, Ltd. Monoclonal antibody, hybridoma, their production and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
EP0593065B1 (en) * 1985-09-12 2002-08-21 Scios Inc. Recombinant fibroblast growth factors
JP2526965B2 (en) * 1987-02-24 1996-08-21 武田薬品工業株式会社 Muteins, DNAs and their uses

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288687A2 (en) * 1987-03-03 1988-11-02 Takeda Chemical Industries, Ltd. Monoclonal antibody, hybridoma, their production and use thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 51, no. 3, 1987, pages 187-200, Elsevier Scientific Publishers Ireland, Ltd; J. BERTOLINI et al.: "Isolation, characterisation and tissue localisation of an N-terminal-truncated variant of fibroblast growth factor" *
PROC. NATL. ACAD. SCI. USA, vol. 84, April 1987, pages 1839-1843; M. KLAGSBRUN et al.: "Multiple forms of basic fibroblast growth factor: Amino-terminal cleavages by tumor cell- and brain cell- derived acid proteinases" *
REGULATORY PEPTIDES, vol. 16, no. 2, 1986, pages 135-145, Elsevier Science Publishers B.V. (Biomedical Devision); N. UENO et al.: "Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor" *
See also references of WO8810269A1 *

Also Published As

Publication number Publication date
WO1988010269A1 (en) 1988-12-29
JPH03500529A (en) 1991-02-07
EP0364481A1 (en) 1990-04-25

Similar Documents

Publication Publication Date Title
GB8811772D0 (en) Groving insert
GR862367B (en) Growth factors
GB8803671D0 (en) Anglers aid
EP0364481A4 (en) Growth factors
ZA889438B (en) N-hydroxy-5-phenyl-2 furancarboximidamides useful
AU98521S (en) Sea - or drag - anchor
GB2207156B (en) Greenhouse
GB8728915D0 (en) Glasshouse
GB8827118D0 (en) Cloche
AU1961188A (en) Growth factors
GB8720870D0 (en) Crystal growth
CA59730S (en) Hydroscope
CA59451S (en) Television-receiver
CA58156S (en) Cintre
CA57871S (en) Filterware
SU1568912A1 (en) Soil-tilling implement
CS483587A1 (en) Privod kvapaliny do stredove vykyvneho priamociareho hydromotora
CS322587A1 (en) Ztekucujici prisada do betonovych zamesi
CS675087A1 (en) Uchyceni nadoby ocelarskeho konvertoru do nosneho kruhu
CS81587A1 (en) Vkladacia stielka do obuvi siteho typu
GB8713833D0 (en) Greenhouse
AU101100S (en) Artificial flower
CS297687A1 (en) Indikator bodovej korozie ocelovej vystuze v betone
CS806487A1 (en) Zpusob elektrometrickeho stanoveni chloridu v pritomnosti sulfidicke nebo hydrogensulfidicke skupiny
CS675187A1 (en) Ulozeni nadoby ocelarskeho konvertoru v nosnem kruhu

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19891219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19911202

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19921007

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930420